Dohmen Life Science Services (DLSS) Selects ArisGlobal's LifeSphereŽ Safety MultiVigilance Multi-Tenant Cloud Platform, Adding Cognitive Computing to Best-in-Class Medical Communication, PV & Commercial Services

Tuesday, August 14, 2018 Lifestyle News
Email Print This Page Comment bookmark
Font : A-A+

MIAMI, August 14, 2018 /PRNewswire/ --

ArisGlobal, a leading life sciences technology provider,

announced that Dohmen Life Science Services (DLSS), a leading provider of outsourced commercialization services within the life sciences industry, selected LifeSphere Safety MultiVigilance as an additional pharmacovigilance platform to
manage case processing for its global clientele of pharma and medical device companies.

     (Logo: )

LifeSphere Safety MultiVigilance leverages the LifeSphereŽ platform, which uses state-of-the-art robotic and cognitive computing technologies like natural language processing (NLP) and machine learning to enable automation. The solution has the potential to transform the practice of pharmacovigilance from a tedious, resource intensive process to a dynamic and efficient practice. Over the past year, ArisGlobal's highly skilled team of pharmacovigilance and cognitive computing experts have been actively involved in developing the next-generation, automation-enabled technology that is revolutionizing the way pharmacovigilance case processing is done today.

"As our global business rapidly expands and the regulatory environment becomes more complex, we recognize the value that cognitive automation brings to the traditionally manual pharmacovigilance process," shares Herb Lee, Senior Vice President, Medical Communications & PV, DLSS. "The LifeSphere Platforms gives our clients access to a complete PV service solution powered by our experienced PV staff, backed by the added efficiency of automation and data analysis. Every investment we make is designed to help our clients improve operational efficiency, capture revenue faster, maintain compliance, and most importantly, best serve the needs of their patients," added Lee.

The platform features a pre-configured, tested and ready-to-use application, provided and hosted for DLSS. Interactive data monitoring and analysis capabilities across multiple tenants helps DLSS provide its clients with critical insights to track daily operations and make informed strategic long-term decisions.

"ArisGlobal's LifeSphere Safety MultiVigilance multi-tenant cloud solution provides robust security, scalability, seamless upgrades and cutting edge cognitive computing technology leading to better compliance to global regulations and cost-effective pharmacovigilance processes," said Sankesh Abbhi, President and CEO, ArisGlobal.

Learn more: LifeSphere Safety MultiVigilance

About ArisGlobal   ArisGlobal is a visionary technology company that's transforming the way today's most successful life sciences companies develop breakthroughs and bring new products to market. The ArisGlobal LifeSphereŽ cognitive technology platform integrates machine-learning capabilities to automate the core functions of the product lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, our cognitive platform delivers actionable insights, boosts efficiency, ensures compliance, and lowers total cost of ownership through multi-tenancy.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India and Japan. Visit, or follow ArisGlobal on LinkedIn and Twitter.

About Dohmen Life Science Services Now part of a growing life sciences services platform owned by Water Street Healthcare Partners and JLL Partners, DLSS provides biopharma and medical device companies with a wide array of outsourced services for patient support, channel distribution, regulatory strategy, compliance and finance. The portfolio of solutions is designed to simplify commercialization, optimize market access and build share for new and existing therapies. Visit to learn more.

SOURCE ArisGlobal

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store